|
1
|
Jamora C and Fuchs E: Intercellular
adhesion, signalling and the cytoskeleton. Nat Cell Biol.
4:E101–E108. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Green KJ and Simpson CL: Desmosomes: New
perspectives on a classic. J Invest Dermatol. 127:2499–2515. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dusek RL and Attardi LD: Desmosomes: New
perpetrators in tumour suppression. Nat Rev Cancer. 11:317–323.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
South AP, Wan H, Stone MG,
Dopping-Hepenstal PJ, Purkis PE, Marshall JF, Leigh IM, Eady RA,
Hart IR and McGrath JA: Lack of plakophilin 1 increases
keratinocyte migration and reduces desmosome stability. J Cell Sci.
116:3303–3314. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yin T and Green KJ: Regulation of
desmosome assembly and adhesion. Semin Cell Dev Biol. 15:665–677.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takes RP: Staging of the neck in patients
with head and neck squamous cell cancer: Imaging techniques and
biomarkers. Oral Oncol. 40:656–667. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karatzanis AD, Waldfahrer F, Psychogios G,
Hornung J, Zenk J, Velegrakis GA and Iro H: Resection margins and
other prognostic factors regarding surgically treated glottic
carcinomas. J Surg Oncol. 101:131–136. 2010.PubMed/NCBI
|
|
8
|
Fan S, Tang QL, Lin YJ, Chen WL, Li JS,
Huang ZQ, Yang ZH, Wang YY, Zhang DM, Wang HJ, et al: A review of
clinical and histological parameters associated with contralateral
neck metastases in oral squamous cell carcinoma. Int J Oral Sci.
3:180–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lea J, Bachar G, Sawka AM, Lakra DC,
Gilbert RW, Irish JC, Brown DH, Gullane PJ and Goldstein DP:
Metastases to level IIb in squamous cell carcinoma of the oral
cavity: A systematic review and meta-analysis. Head Neck.
32:184–190. 2010.PubMed/NCBI
|
|
10
|
Okura M, Aikawa T, Sawai NY, Iida S and
Kogo M: Decision analysis and treatment threshold in a management
for the N0 neck of the oral cavity carcinoma. Oral Oncol.
45:908–911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Greenberg JS, Fowler R, Gomez J, Mo V,
Roberts D, El Naggar AK and Myers JN: Extent of extracapsular
spread: A critical prognosticator in oral tongue cancer. Cancer.
97:1464–1470. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Casiglia J and Woo SB: A comprehensive
review of oral cancer. Gen Dent. 49:72–82. 2001.PubMed/NCBI
|
|
14
|
Kitajima D, Kasamatsu A, Nakashima D,
Miyamoto I, Kimura Y, Saito T, Suzuki T, Endo-Sakamoto Y, Shiiba M,
Tanzawa H and Uzawa K: Tie2 regulates tumor metastasis of oral
squamous cell carcinomas. J Cancer. 7:600–607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dumont DJ, Gradwohl G, Fong GH, Puri MC,
Gertsenstein M, Auerbach A and Breitman ML: Dominant-negative and
targeted null mutations in the endothelial receptor tyrosine
kinase, tek, reveal a critical role in vasculogenesis of the
embryo. Genes Dev. 8:1897–1909. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suri C, Jones PF, Patan S, Bartunkova S,
Maisonpierre PC, Davis S, Sato TN and Yancopoulos GD: Requisite
role of angiopoietin-1, a ligand for the TIE2 receptor, during
embryonic angiogenesis. Cell. 87:1171–1180. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sato TN, Tozawa Y, Deutsch U,
Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T,
Wolburg H, Risau W and Qin Y: Distinct roles of the receptor
tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature.
376:70–74. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yancopoulos GD, Davis S, Gale NW, Rudge
JS, Wiegand SJ and Holash J: Vascular-specific growth factors and
blood vessel formation. Nature. 407:242–248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peters KG, Kontos CD, Lin PC, Wong AL, Rao
P, Huang L, Dewhirst MW and Sankar S: Functional significance of
Tie2 signaling in the adult vasculature. Recent Prog Horm Res.
59:51–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brindle NP, Saharinen P and Alitalo K:
Signaling and functions of angiopoietin-1 in vascular protection.
Circ Res. 98:1014–1023. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eklund L and Olsen BR: Tie receptors and
their angiopoietin ligands are context-dependent regulators of
vascular remodeling. Exp Cell Res. 312:630–641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pfaff D, Fiedler U and Augustin HG:
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems
as regulators of cell trafficking. J Leukoc Biol. 80:719–726. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Davis S, Aldrich TH, Jones PF, Acheson A,
Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre
PC and Yancopoulos GD: Isolation of angiopoietin-1, a ligand for
the TIE2 receptor, by secretion-trap expression cloning. Cell.
87:1161–1169. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jones N, Iljin K, Dumont DJ and Alitalo K:
Tie receptors: New modulators of angiogenic and lymphangiogenic
responses. Nat Rev Mol Cell Biol. 2:257–267. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maisonpierre PC, Suri C, Jones PF,
Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J,
Aldrich TH, Papadopoulos N, et al: Angiopoietin-2, a natural
antagonist for Tie2 that disrupts in vivo angiogenesis. Science.
277:55–60. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gamble JR, Drew J, Trezise L, Underwood A,
Parsons M, Kasminkas L, Rudge J, Yancopoulos G and Vadas MA:
Angiopoietin-1 is an antipermeability and anti-inflammatory agent
in vitro and targets cell junctions. Circ Res. 87:603–607. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeon BH, Khanday F, Deshpande S, Haile A,
Ozaki M and Irani K: Tie-ing the antiinflammatory effect of
angiopoietin-1 to inhibition of NF-kappaB. Circ Res. 92:586–588.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ramsauer M and D'Amore PA: Getting Tie(2)d
up in angiogenesis. J Clin Invest. 110:1615–1617. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cho CH, Kammerer RA, Lee HJ, Yasunaga K,
Kim KT, Choi HH, Kim W, Kim SH, Park SK, Lee GM and Koh GY:
Designed angiopoietin-1 variant, COMP-Ang1, protects against
radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci
USA. 101:5553–5558. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stratmann A, Risau W and Plate KH: Cell
type-specific expression of angiopoietin-1 and angiopoietin-2
suggests a role in glioblastoma angiogenesis. Am J Pathol.
153:1459–1466. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sugimachi K, Tanaka S, Taguchi K, Aishima
S, Shimada M and Tsuneyoshi M: Angiopoietin switching regulates
angiogenesis and progression of human hepatocellular carcinoma. J
Clin Pathol. 56:854–860. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pindborg JJ, Reichart PA, Smith CJ and van
der Waal I: Histological typing of cancer and precancer of the oral
mucosaWorld Health Organization classification of tumours. 2nd
edition. Springer-Verlag; Berlin Heidelberg:
|
|
33
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumors. 7th edition. New York:
Wiley-Liss; 2009
|
|
34
|
Minakawa Y, Kasamatsu A, Koike H, Higo M,
Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H
and Uzawa K: Kinesin family member 4A: A potential predictor for
progression of human oral cancer. PLoS One. 8:e859512013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamatoji M, Kasamatsu A, Kouzu Y, Koike H,
Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
Dermatopontin: A potential predictor for metastasis of human oral
cancer. Int J Cancer. 130:2903–2911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Uchida F, Uzawa K, Kasamatsu A, Takatori
H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Bukawa H:
Overexpression of cell cycle regulator CDCA3 promotes oral cancer
progression by enhancing cell proliferation with prevention of G1
phase arrest. BMC Cancer. 12:3212012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Unozawa M, Kasamatsu A, Higo M, Fukumoto
C, Koyama T, Sakazume T, Nakashima D, Ogawara K, Yokoe H, Shiiba M,
et al: Cavin-2 in oral cancer: A potential predictor for tumor
progression. Mol Carcinog. 55:1037–1047. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ramanathan R, Wilkemeyer MF, Mittal B,
Perides G and Charness ME: Alcohol inhibits cell-cell adhesion
mediated by human L1. J Cell Biol. 133:381–390. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tripathi V, Popescu NC and Zimonjic DB:
DLC1 induces expression of E-cadherin in prostate cancer cells
through Rho pathway and suppresses invasion. Oncogene. 33:724–733.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kasamatsu A, Uzawa K, Nakashima D, Koike
H, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Galectin-9 as a
regulator of cellular adhesion in human oral squamous cell
carcinoma cell lines. Int J Mol Med. 16:269–273. 2005.PubMed/NCBI
|
|
41
|
Endo Y, Uzawa K, Mochida Y, Shiiba M,
Bukawa H, Yokoe H and Tanzawa H: Sarcoendoplasmic reticulum Ca(2+)
ATPase type 2 downregulated in human oral squamous cell carcinoma.
Int J Cancer. 110:225–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lombardi DP, Geradts J, Foley JF, Chiao C,
Lamb PW and Barrett JC: Loss of KAI1 expression in the progression
of colorectal cancer. Cancer Res. 59:5724–5731. 1999.PubMed/NCBI
|
|
43
|
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba
M, Bukawa H, Yokoe H, Seki N and Tanzawa H: Aberrant expression of
RAB1A in human tongue cancer. Br J Cancer. 92:1915–1921. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Baba T, Sakamoto Y, Kasamatsu A, Minakawa
Y, Yokota S, Higo M, Yokoe H, Ogawara K, Shiiba M, Tanzawa H and
Uzawa K: Persephin: A potential key component in human oral cancer
progression through the RET receptor tyrosine
kinase-mitogen-activated protein kinase signaling pathway. Mol
Carcinog. 54:608–617. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ishige S, Kasamatsu A, Ogoshi K, Saito Y,
Usukura K, Yokoe H, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, et al:
Decreased expression of kallikrein-related peptidase 13: Possible
contribution to metastasis of human oral cancer. Mol Carcinog.
53:557–565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Saharinen P, Eklund L, Miettinen J,
Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D,
Deutsch U, Koh GY, et al: Angiopoietins assemble distinct Tie2
signalling complexes in endothelial cell-cell and cell-matrix
contacts. Nat Cell Biol. 10:527–537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Buehler D, Rush P, Hasenstein JR, Rice SR,
Hafez GR, Longley BJ and Kozak KR: Expression of angiopoietin-TIE
system components in angiosarcoma. Mod Pathol. 26:1032–1040. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wong AL, Haroon ZA, Werner S, Dewhirst MW,
Greenberg CS and Peters KG: Tie2 expression and phosphorylation in
angiogenic and quiescent adult tissues. Circ Res. 81:567–574. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Thurston G, Suri C, Smith K, McClain J,
Sato TN, Yancopoulos GD and McDonald DM: Leakage-resistant blood
vessels in mice transgenically overexpressing angiopoietin-1.
Science. 286:2511–2514. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Koblizek TI, Weiss C, Yancopoulos GD,
Deutsch U and Risau W: Angiopoietin-1 induces sprouting
angiogenesis in vitro. Curr Biol. 8:529–532. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Papapetropoulos A, García-Cardeña G,
Dengler TJ, Maisonpierre PC, Yancopoulos GD and Sessa WC: Direct
actions of angiopoietin-1 on human endothelium: Evidence for
network stabilization, cell survival, and interaction with other
angiogenic growth factors. Lab Invest. 79:213–223. 1999.PubMed/NCBI
|
|
52
|
Saharinen P, Kerkelä K, Ekman N, Marron M,
Brindle N, Lee GM, Augustin H, Koh GY and Alitalo K: Multiple
angiopoietin recombinant proteins activate the Tie1 receptor
tyrosine kinase and promote its interaction with Tie2. J Cell Biol.
169:239–243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim S, Lee JC, Cho ES and Kwon J:
COMP-Ang1 promotes chondrogenic and osteogenic differentiation of
multipotent mesenchymal stem cells through the Ang1/Tie2 signaling
pathway. J Orthop Res. 31:1920–1928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kook SH, Lim SS, Cho ES, Lee YH, Han SK,
Lee KY, Kwon J, Hwang JW, Bae CH, Seo YK and Lee JC:
COMP-angiopoietin 1 increases proliferation, differentiation, and
migration of stem-like cells through Tie-2-mediated activation of
p38 MAPK and PI3K/Akt signal transduction pathways. Biochem Biophys
Res Commun. 455:371–377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim
TY, Lee SW, Suh JW, Park KW, Lee HY, et al: Priming with
angiopoietin-1 augments the vasculogenic potential of the
peripheral blood stem cells mobilized with granulocyte
colony-stimulating factor through a novel Tie2/Ets-1 pathway.
Circulation. 120:2240–2250. 2009. View Article : Google Scholar : PubMed/NCBI
|
